SCHEMBL26329790

SCHEMBL26329790

c1ccc(-n2c3ccccc3c3cc4c5ccccc5n(-c5cccc(-c6cccc(-n7c8ccccc8c8ccncc87)c6)c5)c4cc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ATM Q13315 1/20 0.47
CDK4 P11802 3/20 0.41
CDK6 Q00534 3/20 0.41
DYRK1A Q13627 2/20 0.40
MAPT P10636 2/20 0.37
GSK3B P49841 1/20 0.37
KCNH2 Q12809 1/20 0.37
KMT2A Q03164 2/20 0.35
IL1R1 P14778 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
IDO1 P14902 1/20 0.34
MAOA P21397 4/20 0.34
MAOB P27338 4/20 0.34
ACHE P22303 1/20 0.34
CYP17A1 P05093 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21454352 1.00 L3MBTL1 (0.47) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL21454346 0.96 L3MBTL1 (0.49) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL26329794 0.93 KDM4E (0.51) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL5031115 0.92 KDM4E (0.47) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL26329831 0.91 KDM4E (0.44) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL19862608 0.91 KDM4E (0.44) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL15945587 0.91 KDM4E (0.46) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL15945592 0.91 KDM4E (0.46) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL25919402 0.91 KDM4E (0.46) L3MBTL1KDM4EATMCDK4CDK6
SCHEMBL26329792 0.90 KDM4E (0.55) L3MBTL1KDM4EATMCDK4CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723269-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-08 US disclosed
US-11723269-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11723269-B2 Organic electroluminescent materials and devices PUF60, CD99, DDT L3MBTL1 1292/4885KDM4E 3163/4885ATM 3362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.